ENTITY
Shenzhen Hepalink Pharmaceutical

Shenzhen Hepalink Pharmaceutical (9989 HK)

97
Analysis
Health Care • China
Shenzhen Hepalink Pharmaceutical is a multinational biopharmaceutical company with core businesses in the heparin industrial chain, large molecule biologics CDMO services, and the research, development, and commercialization of innovative drugs. Its key products include heparin sodium APIs and enoxaparin sodium preparations. The company is headquartered in Shenzhen, China, and was founded in 1998.
more
•03 Apr 2022 11:08

A-H Premium Weekly: Real Estate at 52 Week High

We highlight real estate sector at 52 eek high and stocks at 52w high A-H premium: Flat Glass, Shandong Chenming Paper, CCC , Tianjin Capital, QHD...

Logo
397 Views
Share
•20 Mar 2022 12:17

A/H Premium Weekly: Arb Opportunities Last Week

We highlight average A/H premium was 4.7ppt lower last week, led by consumer discretionary, material and healthcare. 37 stocks reached 52w high...

Logo
368 Views
Share
•13 Mar 2022 15:23

A/H Premium Weekly: BYD, Xinjiang Gold Wind, Ganfeng Lithium

We highlight A/H premium increase led by consumer Staples and consumer discretionary and industrials sectors, and stocks at 52 week high: BYD,...

Logo
410 Views
Share
•06 Mar 2022 11:18

A/H Premium Weekly: 15 Stocks at 52 Week High

We highlight that 15 stocks reached their 52 week high of A/H premium last week, including Xinjiang Gold Wind (2208 HK), Fuyao Glass (3606 HK),...

Logo
467 Views
Share
x